Table 1

 Demographic features of 40 patients with carpometacarpal joint osteoarthritis, randomly assigned to receive placebo or steroid injection to the symptomatic thumb base joint

Clinical featurePlaceboSteroid
Data are numbers or median (95% confidence interval) unless stated otherwise. The Wilcoxon signed rank was used to assess differences between the groups.
CMC, carpometacarpal; VAS, visual analogue score.
Age (years), mean (range)59.3 (46 to 69)60.6 (41 to 71)
Mean duration of symptoms (years)8.27.4
Female/male17/319/1
Family history of hand osteoarthritis1414
Dominant hand injected1416
Bilateral symptoms64
Nodal osteoarthritis present1316
VAS56 (50 to 78)52 (40 to 72)
Joint tenderness2 (1 to 2)2 (1 to 3)
Physician’s global assessment4 (3 to 4)3 (2 to 4)
Patient’s global assessment4 (3 to 4)3 (2 to 4)
Joint stiffness15 (10 to 30)20 (0 to 30)
CMC joint space narrowing3 (2 to 4)3 (2 to 4)
CMC osteophyte grade3 (2 to 4)3 (2 to 4)